- Home
- HFBL vs PDSB Comparison
HFBL vs PDSB Comparison
Compare HFBL & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- PDSB
- Stock Information
- Founded
- HFBL 1924
- PDSB 2005
- Country
- HFBL United States
- PDSB United States
- Employees
- HFBL N/A
- PDSB N/A
- Industry
- HFBL Savings Institutions
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- HFBL Finance
- PDSB Health Care
- Exchange
- HFBL Nasdaq
- PDSB Nasdaq
- Market Cap
- HFBL 41.6M
- PDSB 44.5M
- IPO Year
- HFBL N/A
- PDSB N/A
- Fundamental
- Price
- HFBL $14.54
- PDSB $0.94
- Analyst Decision
- HFBL
- PDSB Strong Buy
- Analyst Count
- HFBL 0
- PDSB 2
- Target Price
- HFBL N/A
- PDSB $10.00
- AVG Volume (30 Days)
- HFBL 1.8K
- PDSB 489.6K
- Earning Date
- HFBL 10-23-2025
- PDSB 11-13-2025
- Dividend Yield
- HFBL 3.70%
- PDSB N/A
- EPS Growth
- HFBL 35.20
- PDSB N/A
- EPS
- HFBL 1.47
- PDSB N/A
- Revenue
- HFBL $21,720,000.00
- PDSB N/A
- Revenue This Year
- HFBL N/A
- PDSB N/A
- Revenue Next Year
- HFBL N/A
- PDSB N/A
- P/E Ratio
- HFBL $9.94
- PDSB N/A
- Revenue Growth
- HFBL 10.10
- PDSB N/A
- 52 Week Low
- HFBL $11.75
- PDSB $0.85
- 52 Week High
- HFBL $14.86
- PDSB $3.48
- Technical
- Relative Strength Index (RSI)
- HFBL 71.13
- PDSB 40.57
- Support Level
- HFBL $14.00
- PDSB $0.89
- Resistance Level
- HFBL $14.20
- PDSB $1.03
- Average True Range (ATR)
- HFBL 0.11
- PDSB 0.06
- MACD
- HFBL 0.02
- PDSB 0.00
- Stochastic Oscillator
- HFBL 72.41
- PDSB 31.67
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.